arrow
Back
I

Immunogen, Inc.

Scholars279
Papers135
Citations9
Related Papers (132)
Publication Date
Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary End Points From the EMBARK Trial
err2026-05-01
err6
PREAI
errShore, Neal D.; Gleave, Martin; De Giorgi, Ugo; Rannikko, Antti; Pieczonka, Christopher M.; Sridharan, Swetha; Brasso, Klaus; Woo, Henry H.; Gomez Caamano, Antonio; Saranchuk, Jeff W.; Nordquist, Luke T.; Ferreira, Ubirajara; Tang, Yiyun; Rosbrook, Brad; Haas, Gabriel P.; Rosales, Matt; Zohren, Fabian; Tarazi, Jamal; Freedland, Stephen J.
errShare
errSave
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer
err2025-07-22
err0
PREAI
errUrsula A. Matulonis; Ignace Vergote; Kathleen N. Moore; Lainie P. Martin; Cesar M. Castro; Lucy Gilbert; Yu Xia; Michael Method; James Stec; Michael J. Birrer; David M. O'Malley
errShare
errSave
The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third- line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial
err2025-03-01
err0
errOAAI
errSecord, A. Alvarez; Lewin, S. N.; Murphy, C. G.; Cecere, S. C.; Barquin, A.; Galvez-Montosa, F.; Mathews, C. A.; Konecny, G. E.; Ray-Coquard, I.; Oakni, A.; Perez, M. J. Rubio; Bonaventura, A.; Diver, E. J.; Ayuk, S. -M; Wang, Y.; Corr, B. R.; Salutari, V.
errShare
errSave
Preclinical Characterization of the Anti-Leukemia Activity of the CD123 Antibody-Drug Conjugate, Pivekimab Sunirine (IMGN632)
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errCole, Frances M.; Laszlo, George S.; Lunn-Halbert, Margaret C.; Kehret, Allie R.; Zweidler-McKay, Patrick A.; Rodriguez-Arboli, Eduardo; Wu, David; Nyberg, Kyle E.; Li, Junyang; Lim, Sheryl Y. T.; Lakshmikanthan, Sribalaji; Walter, Roland B.
errShare
errSave
Results from a phase 1/2, first-in-human, dose escalation and dose expansion study of an investigational anti-ADAM9 antibody-drug conjugate IMGC936 in patients with advanced solid tumors
err2024-10-01
err0
PREAI
errSubbiah, V.; Falchook, G.; Davis, A. A.; Wang, J. S.; de Miguel, M.; Santoro, A.; Maur, M.; Aljumaily, R.; Boni, V.; de Speville, B. Doger; Sun, Y.; Du, Y.; Lakshmikanthan, S.; Bedse, G.; Ward, A.; Zweidler-McKay, P.; Gandhi, L.
errShare
errSave
Mirvetuximab soravtansine (MIRV) in recurrent platinum-sensitive ovarian cancer (PSOC) with high folate receptor-alpha (FRα) expression: Results from the PICCOLO trial
err2024-09-01
err5
PREAI
errSecord, A. A.; Corr, B. R.; Lewin, S.; Diver, E.; Ayuk, S-M.; Wang, Y.; Murphy, C.; Salutari, V.; Garcia, A. Barquin; Montosa, F. Galvez; Ray-Coquard, I. L.; Mathews, C.; Konecny, G. E.; Oaknin, A.; Perez, M. J. Rubio; Bonaventura, A.; Pignata, S.
errShare
errSave
Phase III MIRASOL trial: Updated overall survival results of mirvetuximab soravtansine (MIRV) vs. investigator's choice chemotherapy (ICC) in patients (pts) with platinum-resistant ovarian cancer (PROC) and high folate receptor-alpha (FRa) expression
err2024-09-01
err1
PREAI
errCoffman, L. Gardner; You, B.; Hamilton, E. P.; Garcia, Y. Garcia; Moore, K. N.; Sonnenburg, D.; Scambia, G.; Derio, S.; Pepin, J. Thomes; Klasa-Mazurkiewicz, D.; Tromp, J.; Breuer, S.; Weroha, S.; Sukhina, O.; Wang, Y.; Stec, J. J.; Van Gorp, T.
errShare
errSave
Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group Report
errLEUKEMIA
IF13.4
err2024-02-15
err5
errOAAI
errDelrocco, N. J.; Loh, M. L.; Borowitz, M. J.; Gupta, S.; Rabin, K. R.; Zweidler-McKay, P.; Maloney, K. W.; Mattano, L. A.; Larsen, E.; Angiolillo, A.; Schore, R. J.; Burke, M. J.; Salzer, W. L.; Wood, B. L.; Carroll, A. J.; Heerema, N. A.; Reshmi, S. C.; Gastier-Foster, J. M.; Harvey, R.; Chen, I. M.; Roberts, K. G.; Mullighan, C. G.; Willman, C.; Winick, N.; Carroll, W. L.; Rau, R. E.; Teachey, D. T.; Hunger, S. P.; Raetz, E. A.; Devidas, M.; Kairalla, J. A.
errShare
errSave
Development of an FRa Companion Diagnostic Immunohistochemical Assay for Mirvetuximab Soravtansine
err2024-01-29
err2
errOAAI
errJames, Racheal L.; Sisserson, Taryn; Cai, Zhuangyu; Dumas, Megan E.; Inge, Landon J.; Ranger-Moore, James; Mason, Albert; Sloss, Callum M.; Mcarthur, Katherine
errShare
errSave
Population pharmacokinetics of mirvetuximab soravtansine in patients with folate receptor-α positive ovarian cancer: The antibody-drug conjugate, payload and metabolite
err2023-11-13
err2
errOAAI
errTu, Ya-Ping; Hanze, Eva; Zhu, Fengying; Lagraauw, H. Maxime; Sloss, Callum M.; Method, Michael; Esteves, Brooke; Westin, Eric H.; Berkenblit, Anna
errShare
errSave
Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Male Subjects
err2023-04-18
err1
errOAAI
errGupta, Vipul K.; Maier, Gary; Gasink, Leanne; Ek, Amanda; Fudeman, Mary; Srivastava, Praveen; Talley, Angela
errShare
errSave
Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932
errLEUKEMIA
IF13.4
err2023-03-25
err6
PREAI
errSchore, Reuven J. J.; Angiolillo, Anne L. L.; Kairalla, John A. A.; Devidas, Meenakshi; Rabin, Karen R. R.; Zweidler-McKay, Patrick; Borowitz, Michael J. J.; Wood, Brent; Carroll, Andrew J. J.; Heerema, Nyla A. A.; Relling, Mary V. V.; Hitzler, Johann; Kadan-Lottick, Nina S. S.; Maloney, Kelly; Wang, Cindy; Carroll, William L. L.; Winick, Naomi J. J.; Raetz, Elizabeth A. A.; Loh, Mignon L. L.; Hunger, Stephen P. P.
errShare
errSave
Exposure response (ER) analysis for efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer
err2022-09-01
err1
errOAAI
errMatulonis, U. A.; Moore, K. N.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Marin, M. Romeo; Harter, P.; Murphy, C.; Tu, Y.; Zhu, F.; Esteves, B.; Method, M.; Birrer, M. J.; Coleman, R. L.; O'Malley, D.
errShare
errSave
Population pharmacokinetic (PK) analysis of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer
err2022-09-01
err3
errOAAI
errMoore, K. N.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Romeo Marin, M.; Harter, P.; Murphy, C.; Tu, Y.; Zhu, F.; Esteves, B.; Method, M.; Birrer, M. J.; Coleman, R. L.; Matulonis, U. A.; O'Malley, D.
errShare
errSave
Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)
err2022-09-01
err2
errOAAI
errMoore, K. N.; Oza, A. M.; Colombo, N.; Oaknin, A.; Scambia, G.; Lorusso, D.; Banerjee, S.; Murphy, C.; Konner, J.; Lim, P.; Prasad-Hayes, M.; Monk, B. J.; Wang, J.; Birrer, M. J.; Vergote, I. B.
errShare
errSave
Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors
err2022-05-05
err9
errOAAI
errScribner, Juniper A.; Hicks, Stuart W.; Sinkevicius, Kerstin W.; Yoder, Nicholas C.; Diedrich, Gundo; Brown, Jennifer G.; Lucas, Jacquelynn; Fuller, Megan E.; Son, Thomas; Dastur, Anahita; Hooley, Jeff; Espelin, Christopher; Themeles, Marian; Chen, Francine Z.; Li, Ying; Chiechi, Michael; Lee, Jenny; Barat, Bhaswati; Widjaja, Lusiana; Gorlatov, Sergey; Tamura, James; Ciccarone, Valentina; Ab, Olga; McEachem, Kerry A.; Koenig, Scott; Westin, Eric H.; Moore, Paul A.; Chittenden, Thomas; Gregory, Richard J.; Bonvini, Ezio; Loo, Deryk
errShare
errSave
Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody-Drug Conjugate in Patient-derived Xenografts
err2020-10-02
err9
errOAAI
errAbu-Yousif, Adnan O.; Cvet, Donna; Gallery, Melissa; Bannerman, Bret M.; Ganno, Michelle L.; Smith, Michael D.; Lai, Katharine C.; Keating, Thomas A.; Stringer, Bradley; Kamali, Afrand; Eng, Kurt; Koseoglu, Secil; Zhu, Andy; Xia, Cindy Q.; Landen, Melissa Saylor; Borland, Maria; Robertson, Robbie; Bolleddula, Jayaprakasam; Qian, Mark G.; Fretland, Jennifer; Veiby, O. Petter
errShare
errSave
IMGN151-A next generation folate receptor alpha targeting antibody drug conjugate active against tumors with low, medium and high receptor expression
err2020-08-15
err7
PREAI
errAb, Olga; Bartle, Laura M.; Lanieri, Leanne; Ponte, Jose F.; Qiu, Qifeng; Sikka, Surina; Costoplus, Juliet A.; Deats, Wayne; Yoder, Nicholas C.; Widdison, Wayne C.; Mucciarone, Katherine; Selvitelli, Kate; Chen, Ying; Kohli, Neeraj; Chittenden, Thomas; Gregory, Richard; Setiady, Yulius; Westin, Eric H.
errShare
errSave
Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children's Oncology Group Study AALL1131
err2020-08-10
err47
errOAAI
errSalzer, Wanda L.; Burke, Michael J.; Devidas, Meenakshi; Dai, Yunfeng; Hardy, Kristina K.; Kairalla, John A.; Gore, Lia; Hilden, Joanne M.; Larsen, Eric; Rabin, Karen R.; Zweidler-McKay, Patrick A.; Borowitz, Michael J.; Wood, Brent; Heerema, Nyla A.; Carroll, Andrew J.; Winick, Naomi; Carroll, William L.; Raetz, Elizabeth A.; Loh, Mignon L.; Hunger, Stephen P.
errShare
errSave